title: [Antidepressants, antipsychotics and metabolic risks].
authors.affiliation: Klinik und Poliklinik für Pschiatrie, Psychosomatik und Psychotherapie der Universität regensburg an Bezirksklinikum. markus.wittmann@medbo.de
authors.forename: M
authors.initials: M
authors.lastname: Wittmann
authors.forename: B
authors.initials: B
authors.lastname: Hübner-Liebermann
authors.forename: K
authors.initials: K
authors.lastname: Wenzel-Seifert
authors.forename: H
authors.initials: H
authors.lastname: Hausner
mesh_terms: D000928:Antidepressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003865:Major Depressive Disorder / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced* / Q000175:diagnosis; D005858:Germany; D019983:Guideline Adherence; D006801:Humans; D011618:Psychotic Disorders / Q000188:drug therapy*; D012306:Risk
chemical_list: D000928:Antidepressive Agents; D014150:Antipsychotic Agents